Pharmafile Logo
Pharmafocus logo
Advanced Search

PR heavyweights launch new agency

October 29, 2003

Former managing directors of Shire Health London and Cohn & Wolfe Healthcare have joined forces to launch a new independent, …

News

New R&D chief as Merck files Erbitux

October 29, 2003

German pharmaceutical Merck KgaA has appointed a new head of clinical research and development following a major R&D re-organisation. Dr …

News

Liver test takes shine off Exanta

October 29, 2003

AstraZeneca has admitted that patients on its new anti-clotting drug Exanta will need liver tests, denting the drug's profile as …

News

US approval for breakthrough diabetes device

October 29, 2003

The first integrated glucose meter and insulin pump has been approved by the FDA, bringing the goal of an 'artificial …

News

Pharmacy reform must look at ‘bigger picture’

October 29, 2003

MPs have criticised a report recommending opening up community pharmacy to greater competition, saying its value had been misunderstood.David Hinchcliffe, …

News

Generic threat to Lilly’s biggest seller

October 29, 2003

A court challenge to Eli Lilly's patent on its number one drug Zyprexa could spell serious trouble for the company, …

News

AstraZeneca buoyed by Crestor clearance

October 29, 2003

AstraZeneca's new statin drug has received unanimous approval by a key FDA panel, and now looks set to be launched …

News

CROs continue to extend global reach

October 29, 2003

Contract research organisations from Europe and the US are continuing to expand their operations in order to meet the pharmaceutical …

News

Call for free price-setting across Europe

October 29, 2003

Pharmaceutical companies should be allowed to set their own prices in all European Union countries in order to bring a …

News

GSK and Novartis settle over Augmentin

October 29, 2003

GlaxoSmithKline has reached an agreement with Novartis in its court action over stolen trade secrets for its antibiotic Augmentin.Novartis will …

News

OGS withdraws CAT offer recommendation

October 29, 2003

Oxford GlycoSciences has withdrawn its support of Cambridge Antibody Technology's £110 million all-share bid for the company, despite believing a …

News

NiQuitin PR steps up a gear with Cohn & Wolfe

October 29, 2003

News

Foundation hospitals survive Labour revolt

October 29, 2003

Plans for foundation hospitals have been narrowly passed by the House of Commons despite a revolt by Labour MPs that …

News

Schering’s Angeliq approved in Europe

October 29, 2003

Schering's new low dose HRT product Angeliq has gained mutual recognition in the European Union, with launches expected across the …

News

Pharma urged to reduce animal testing

October 29, 2003

The pharmaceutical industry should test more drugs in humans at a pre-clinical stage to reduce numbers of primates used, a …

News

Trial failure puts spotlight on Celltech pipeline

October 29, 2003

News

Blockbuster combination unveiled as Pfizer marches on

October 29, 2003

Pfizer is to launch a new double-blockbuster cardiovascular product to help further its position as the Goliath of the pharmaceutical …

News

Profits continue to plummet at Schering-Plough

October 29, 2003

Schering-Plough has issued its third earnings warning this year as it continues to suffer under an onslaught from generic competition.The …

News

Faster market access for generics in US

October 29, 2003

Laws governing the entry of generic drugs on the US market are to be streamlined in an effort to cut …

News

AstraZeneca rises on Crestor hopes

October 29, 2003

AstraZeneca made significant stock market gains following indications its new superstatin Crestor will receive a positive review from US regulatory …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026